Developmental Pharmacology (R01)
National Institutes of Health · Opportunity PAR-07-416
Deadline
Rolling / TBD
Multiple Receipt Dates - See Link to Full Announcement for details.
Award range
— – —
Total program funding
—
PostedJuly 24, 2007
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
About this opportunity
-Purpose. To encourage multidisciplinary , investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across -Developmental periods from fetal life to adolescence. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | National Institutes of Health | November 16, 2026 | $50k | Nonprofits |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | National Institutes of Health | November 18, 2026 | — | Nonprofits |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | National Institutes of Health | November 18, 2026 | — | Nonprofits |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | National Institutes of Health | January 7, 2027 | — | Nonprofits |